Elevated Liver Enzymes
A patient's labs come back with a mild bump in ALT or AST, and they feel fine. This shows up constantly in primary care. The job is to sort hepatocellular vs cholestatic patterns, rule out the dangerous causes, and decide when to refer. Here's a workflow you can actually use in clinic.
What the numbers mean (quick refresher)
- ALT: More liver-specific; lives inside hepatocytes. ULN: ~20–40 IU/L (lab-specific).
- AST: Found in liver, muscle, heart, and RBCs. Exercise or muscle injury can elevate it. ULN: ~15–40 IU/L.
- ALP: From bile ducts, bone, and placenta. ULN: ~40–120 IU/L (varies).
If ALP is up, confirm a hepatic source with GGT or 5′-nucleotidase.
Rule-of-thumb patterns
- ALT > AST → viral hepatitis, NAFLD/NASH, drug-induced.
- AST > ALT (≥2:1) → alcohol-associated liver disease, cirrhosis/advanced fibrosis.
- ALP predominant → cholestasis (bile duct), infiltrative disease, or bone.
Severity:
- Mild = <5× ULN
- Moderate = 5–15× ULN
- Severe = >15× ULN (or AST/ALT >1000 → think ischemic, toxic, or acute viral)
First questions (your 2-minute history)
- Red flags? Jaundice, RUQ pain, pruritus, fever, confusion, bleeding, weight loss.
- Alcohol and meds/supplements? Acetaminophen, statins, amiodarone, methotrexate, TB meds, herbals, bodybuilding steroids.
- Metabolic risks? Obesity, T2DM, dyslipidemia (NAFLD/NASH).
- Viral risks? Hep B/C exposures, tattoos, transfusions.
- Muscle injury or exertion? (AST from muscle).
- Pregnancy? (ALP can rise; cholestasis of pregnancy).
Classify the pattern
- Hepatocellular: ALT/AST disproportionately high vs ALP.
- Cholestatic: ALP disproportionately high vs ALT/AST.
- Mixed: Both up (use R-ratio: ≥5 hepatocellular, ≤2 cholestatic, 2–5 mixed).
Initial workup (baseline panel)
- ALT, AST, ALP, total and direct bilirubin
- Albumin, PT/INR
- CBC
- GGT (if ALP up)
- CK (if muscle source suspected)
Targeted tests:
- Viral: HBsAg, anti-HBc, anti-HCV (with reflex HCV RNA)
- Metabolic: fasting lipids, A1c; iron studies + ferritin
- Autoimmune: ANA, ASMA, IgG
- Cholestatic AI: AMA (PBC); MRCP if PSC suspected (IBD)
- Wilson (<40 y): ceruloplasmin ± 24-h urine copper
- α-1 antitrypsin phenotype
- TSH, celiac serologies if unexplained
- Pregnancy test when relevant
Imaging:
- RUQ ultrasound for most persistent or significant abnormalities
- MRCP/ERCP if cholestasis suspected
- Document steatosis if fatty liver; consider FibroScan if available
Common causes by pattern
Hepatocellular (ALT/AST predominant):
- NAFLD/NASH
- Viral hepatitis (A, B, C)
- Alcohol use (AST>ALT)
- DILI (acetaminophen, meds)
- Autoimmune hepatitis
- Ischemic hepatitis (AST/ALT >1000)
- Wilson, hemochromatosis, α-1 antitrypsin deficiency
Cholestatic (ALP predominant):
- Gallstones/choledocholithiasis
- Malignancy (pancreas, cholangiocarcinoma)
- PBC (↑AMA), PSC (IBD history)
- Drug-induced cholestasis (Augmentin, estrogen, steroids)
- Infiltrative disease (sarcoid, malignancy)
- Bone disease (if GGT normal → bone source)
When to refer or act urgently
- Jaundice, elevated INR, low albumin, low platelets, or high bilirubin
- AST/ALT >5× ULN or >1000
- Persistent elevation >6 months
- Suspected autoimmune hepatitis, PSC/PBC, Wilson, hemochromatosis, mass, or biliary obstruction
Management pearls
- Stop alcohol; limit acetaminophen ≤2 g/day until clarified.
- Weight loss 7–10% may normalize enzymes in NAFLD/NASH.
- Vaccinate nonimmune patients for Hep A and B.
- Recheck labs in 6–12 weeks after med or lifestyle changes.
Quick pattern table
| Pattern | Likely causes | First tests to add |
|---|---|---|
| ALT > AST | NAFLD/NASH, viral, DILI | Hep B/C panel, metabolic labs, RUQ US, med review |
| AST > ALT (≥2) | Alcohol disease, advanced fibrosis | AUD screen, GGT, platelet count, RUQ US |
| ALP ↑ (hepatic) | Biliary obstruction, PBC/PSC | GGT, RUQ US → MRCP; AMA, AI labs |
| AST isolated | Muscle, hemolysis | CK, haptoglobin, LDH |
| ALT/AST >1000 | Ischemic, acetaminophen, acute viral | INR, APAP level, viral panel, ED if ill |
Frequently asked questions
A patient on a statin has a mild ALT bump. Do I stop the statin?
Not automatically. Mild elevations on a statin often aren't a reason to stop. Work up the common causes (NAFLD, alcohol, other meds) and use the same pattern-based approach. For the medication-specific piece, see the post on statin intolerance.
How high is too high before I refer?
Refer or act urgently for AST/ALT >5× ULN or >1000, any sign of synthetic dysfunction (elevated INR, low albumin, high bilirubin), or persistent elevation >6 months.
What if ALP is up but ALT/AST are normal?
Confirm the source. A normal GGT points to bone rather than liver. If GGT is up too, work it up as cholestatic with RUQ ultrasound and consider MRCP.
Does an isolated AST elevation always mean liver?
No. AST also comes from muscle and RBCs. Check CK if you suspect a muscle source, and consider hemolysis (haptoglobin, LDH).
Most mild bumps aren't dangerous. The win is recognizing the pattern, catching the red flags, and knowing when to refer. If you want these patterns and cutoffs in one place at the point of care, the Clinical Desk Reference is a $37 quick-reference. Since metabolic risk drives a lot of NAFLD, the hyperlipidemia overview pairs well here, and the Primary Care Clinical Mastery Program (AANP-accredited) goes deeper on lab interpretation.
Education only. Use clinical judgment and your local guidelines.
Written by Allison Sowders, MSN, APRN, FNP-BC, a practicing primary care nurse practitioner and founder of Nurse Practitioner Mentor. Reviewed July 2026.
Stay connected with news and updates!
Join the mailing list to receive the latest news and updates. Don't worry, your information will not be shared.
We hate SPAM. We will never sell your information, for any reason.